 |
Visterra
Last updated: August 01, 2025
Kevin Bitterman, Founder
USA | Funding: $125.4M (+)
Website: http://www.visterrainc.com
Visterra is a clinical-stage biopharmaceutical company focused on applying its novel Hierotope platform to identify unique disease targets and to design and engineer precision antibody-based biological medicines for infectious and non-infectious diseases.
Website: http://www.visterrainc.com
Visterra is a clinical-stage biopharmaceutical company focused on applying its novel Hierotope platform to identify unique disease targets and to design and engineer precision antibody-based biological medicines for infectious and non-infectious diseases.
